Pleskoff O, Seman M, Alizon M
INSERM U.332, Institut Cochin de Génétique Moléculaire, Paris, France.
J Virol. 1995 Jan;69(1):570-4. doi: 10.1128/JVI.69.1.570-574.1995.
The antiviral effect of MS8209, an amphotericin B derivative, was studied in CD4+ cells transfected with a lacZ gene inducible upon human immunodeficiency virus type 1 (HIV-1) infection. MS8209 was shown to block virus entry after receptor binding and probably before virus-cell membrane fusion, but it had no effect on syncytium formation, although both processes are mediated by HIV-1 envelope proteins and CD4.
两性霉素B衍生物MS8209的抗病毒作用在转染了1型人类免疫缺陷病毒(HIV-1)感染时可诱导表达的lacZ基因的CD4 +细胞中进行了研究。结果显示,MS8209在受体结合后、可能在病毒-细胞膜融合之前阻断病毒进入,但对合胞体形成没有影响,尽管这两个过程均由HIV-1包膜蛋白和CD4介导。